Global drivers of antibiotic resistance by S. Harbarth

Get full text

Development of new antibiotics: taking off finally? by Esther Bettiol, Stephan Harbarth

Get full text

"Antibiotics are not automatic anymore"--the French national campaign to cut antibiotic overuse. by Benedikt Huttner, Stephan Harbarth

Get full text

Antimicrobial Resistance Determinants and Future Control by Stephan Harbarth, Matthew H. Samore

Get full text

Clostridium: transmission difficile? by Stephan Harbarth, Matthew H Samore

Get full text

Linking sustainable use policies to novel economic incentives to stimulate antibiotic research and development by Ursula Theuretzbacher, Christine Årdal, Stephan Harbarth

Get full text

Can the application of the international health regulations to antimicrobial resistance events help to preserve antimicrobials? by Wernli D, Haustein T, Conly J, Harbarth S

Outpatient Antibiotic Use and Prevalence of Antibiotic-Resistant Pneumococci in France and Germany: A Sociocultural Perspective by Stephan Harbarth, Werner Albrich, Christian Brun-Buisson

Get full text

Epidemiology of MRSA at the University of Geneva Hospitals by Fankhauser CM, Schrenzel J, Pittet D, Harbarth S

A ‘whole of United Nations approach’ to tackle antimicrobial resistance? A mapping of the mandate and activities of international organisations by Stephan Harbarth, Didier Pittet, Didier Wernli, Nicolas Levrat

Get full text

Survey of Parental Use of Antimicrobial Drugs for Common Childhood Infections, China by Leesa Lin, Stephan Harbarth, Xiaomin Wang, Xudong Zhou

Get full text

Antibiotic Selection Pressure and Resistance in Streptococcus pneumoniae and Streptococcus pyogenes by Werner C. Albrich, Dominique L. Monnet, Stephan Harbarth

Get full text

Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment Options by Chantal M. Morel, Chantal M. Morel, Marlieke E. A. de Kraker, Stephan Harbarth, Stephan Harbarth, The Enhanced Surveillance Expert Consensus Group (CANSORT-SCI)

Get full text

The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches by Fisman David N, Berger Karin, Szucs Thomas D, Harbarth Stephan

Get full text

Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? by Marlieke E A de Kraker, Andrew J Stewardson, Stephan Harbarth

Get full text

Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry? by Suzanne E. Edwards, Chantal M. Morel, Reinhard Busse, Stephan Harbarth

Get full text

Retrospective data analysis for definition of multidrug resistance in gram-negative bacteria – a consensus proposal by Olivier Friedli, Irene Völlmy, Jacques Schrenzel, Stephan Harbarth, Andreas Kronenberg

Get full text

Should this event be notified to the World Health Organization? reliability of the international health regulations notification assessment process by Thomas Haustein, Helge Hollmeyer, Max Hardiman, Stephan Harbarth, Didier Pittet

Get full text

Estimating the cost of health care-associated infections: mind your p's and q's. by Graves, N, Harbarth, S, Beyersmann, J, Barnett, A, Halton, K, Cooper, B

A call for action: the application of The International Health Regulations to the global threat of antimicrobial resistance. by Didier Wernli, Thomas Haustein, John Conly, Yehuda Carmeli, Ilona Kickbusch, Stephan Harbarth

Get full text